1,2-dipalmitoylphosphatidylcholine has been researched along with Lung Diseases, Interstitial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aslanidis, C; Brasch, F; Frixel, S; Griese, M; Hegermann, J; Höppner, S; Kinting, S; Kröner, C; Lasch, P; Liebisch, G; Reu, S; Schindlbeck, U; Wittmann, T; Zarbock, R | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Lung Diseases, Interstitial
Article | Year |
---|---|
Tools to explore ABCA3 mutations causing interstitial lung disease.
Topics: 1,2-Dipalmitoylphosphatidylcholine; A549 Cells; ATP-Binding Cassette Transporters; Bronchoalveolar Lavage Fluid; Cell Survival; Fatal Outcome; Fluorescent Antibody Technique; Glycosylation; Humans; Immunoblotting; Immunohistochemistry; Infant; Lung; Lung Diseases, Interstitial; Microscopy, Confocal; Microscopy, Electron; Mutation; Pulmonary Surfactant-Associated Protein C; Real-Time Polymerase Chain Reaction | 2016 |